# US Urology Devices Market

> 美国泌尿设备市场研究报告按设备类型（外科器械、诊断设备、耗材、治疗设备）、按应用（泌尿外科、尿失禁、良性前列腺增生、肾结石）、按最终用户（医院、诊所、门诊手术中心）和按性别（男性、女性） - 增长与行业预测2025至2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 19.99%
- **2024:** $ 11.37 Billion
- **2025:** $ 13.89 Billion
- **2035:** $ 84.39 Billion
- **Key Players:** Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), Baxter International (US), Coloplast (DK), Teleflex (US), Cook Medical (US), Stryker (US), UroGen Pharma (US)

**Report ID:** MRFR/MED/14858-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-urology-devices-market-16386

---

## Market Summary

## **US Urology Devices Market Overview**

As per MRFR analysis, the US Urology Devices Market Size was estimated at 7.97 (USD Billion) in 2023. The US Urology Devices Market Industry is expected to grow from 9.75(USD Billion) in 2024 to 88.39 (USD Billion) by 2035. The US Urology Devices Market CAGR (growth rate) is expected to be around 22.19% during the forecast period (2025 - 2035).

### **Key US Urology Devices Market Trends Highlighted**

The US Urology Devices Market is witnessing significant trends driven by a combination of technological advancements and increasing awareness of urological health. The rise in minimally invasive surgical techniques is one of the key market drivers, as many patients and healthcare providers prefer procedures that result in quicker recoveries and reduced complications. Moreover, advancements in robotics and imaging technologies are enabling more precise diagnoses and treatments, addressing a growing demand for improved patient outcomes. The increasing prevalence of urological disorders, including kidney stones and urinary incontinence, is fueling the market as more patients seek effective and innovative treatment options.

Opportunities in the US market are primarily linked to the development of smart urology devices that integrate digital health features, allowing for remote patient monitoring and management of urological conditions. This not only enhances patient engagement but also aligns with the broader trend toward telemedicine, which has gained significant traction in recent years. Additionally, the aging population in the US is expected to increase the demand for urology devices, as older adults are more susceptible to urological issues.

In recent times, there has also been a noticeable trend towards personalized medicine in urology, with patients receiving tailored treatment plans based on genetic or biomarker information.

This shift is transforming the way conditions are diagnosed and treated in the US. Investment in research and development remains strong, as companies strive to innovate and improve existing urology devices. Overall, these trends highlight a dynamic and rapidly evolving landscape in the US Urology Devices Market, characterized by technological innovation, increased patient demand, and a focus on comprehensive care solutions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **US Urology Devices Market Drivers**

### **Increasing Incidence of Urological Disorders**

The incidence of urological disorders in the United States is on the rise, significantly driving the growth of the US Urology Devices Market Industry. According to the National Kidney Foundation, chronic kidney disease affects approximately 37 million adults in the United States. This increasing prevalence of conditions such as urinary incontinence, benign prostatic hyperplasia, and kidney stones points towards the necessity for advanced urology devices for effective management and treatment.

Organizations such as the American Urological Association are actively focusing on research and public awareness campaigns, which adds to the demand for innovative devices that can offer improved patient outcomes, thus revitalizing the US Urology Devices Market. The significant rise in urological conditions necessitates a parallel increase in the availability and development of diagnostic and therapeutic devices catering to these diseases.

### **Technological Advancements in Urology Devices**

Continuous technological advancements are playing a pivotal role in the growth of the US Urology Devices Market Industry. Innovations such as robotic-assisted surgeries and minimally invasive techniques have shown a marked improvement in surgical outcomes. According to the U.S. Food and Drug Administration, the number of new urological devices approved has been increasing annually, highlighting the dynamic nature of this sector. Research and Development expenditures by manufacturers and firms like Medtronic and Boston Scientific focus on developing precise and efficient devices.

These advancements not only improve the effectiveness of treatments but also enhance patient recovery times, contributing to increased satisfaction and the demand for state-of-the-art urological solutions.

### **Aging Population in the United States**

The aging population in the United States is a significant driver affecting the US Urology Devices Market Industry. According to the U.S. Census Bureau, it is projected that by 2034, there will be approximately 77 million older adults aged 65 and over. The incidence of urological disorders, including prostate issues and urinary tract infections, tends to be higher in older adults, leading to an increased need for urological care and devices.

This demographic trend drives demand for specialized urology devices, prompting manufacturers to focus on developing products tailored to the needs of elderly patients. The growing elderly population represents a critical opportunity for the Urology Devices Market, spurring investments in advanced technologies and products designed to cater to this demographic.

## **US Urology Devices Market Segment Insights**

### **Urology Devices Market Device Type Insights**

The US Urology Devices Market showcases a diverse range of device types that significantly contribute to the healthcare landscape. Surgical Instruments occupy a pivotal role, involving tools essential for various urological procedures and driving innovation in minimally invasive techniques, which is transforming patient outcomes. Diagnostic Devices are crucial in early detection and disease monitoring, enabling healthcare professionals to provide timely interventions and personalized treatment plans. The rising prevalence of urological disorders among the aging population further emphasizes their importance in maintaining health standards across the nation.

Consumables represent another vital element, as they encompass various single-use products, ensuring hygienic conditions in procedures and aiding efficiency in urology departments. This category accounts for a majority holding of the overall market due to the consistent need for these products in everyday medical practice. Additionally, Therapeutic Devices are growing in prominence, as they encompass technologies aimed at treating urological conditions, enhancing the quality of life for many patients through innovative therapies. The dynamic US Urology Devices Market segmentation reflects the surging demand supported by factors such as technological advancements, an increase in the aging population, and higher healthcare expenditure.

Strengthening the market further are trends like the rising adoption of robotic-assisted surgeries and telehealth solutions, which continue to reshape the landscape of urological treatments. Amid these opportunities, the market also faces challenges including regulatory hurdles and the need for consistent quality assurance. All these factors collectively underline the significance of the Device Type segment within the US Urology Devices Market and its potential for extensive growth in the coming years.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Urology Devices Market Application Insights**

The US Urology Devices Market encompasses various applications, prominently including Urological Surgery, Urinary Incontinence, Benign Prostatic Hyperplasia, and Kidney Stones. Urological Surgery is essential for managing various urological conditions, driving significant demand for innovative surgical devices and techniques. Urinary Incontinence represents a major concern, particularly among aging populations, highlighting the need for effective treatment solutions and advanced devices that enhance patient quality of life. Benign Prostatic Hyperplasia remains prevalent, necessitating the development of minimally invasive devices that cater to an increasing number of patients seeking relief.

Additionally, the rising incidence of Kidney Stones underscores the importance of specialized devices for diagnosis, treatment, and management, as these conditions often require surgical intervention and ongoing care. Overall, the segmentation of applications within the US Urology Devices Market highlights the diversity of needs and the growing importance of technological advancements to address both common and complex urological issues faced by the population. The market growth is supported by increasing awareness and improved healthcare access, alongside demographic trends indicating an aging population susceptible to urological conditions.

### **Urology Devices Market End User Insights**

The US Urology Devices Market is experiencing significant growth, driven by increased prevalence of urological conditions and advancements in technology. Among the End User segment, hospitals play a crucial role by providing comprehensive urological care and housing advanced urology devices. Clinics also contribute significantly, as they often serve as the first point of consultation for patients and have begun incorporating innovative devices for outpatient procedures, thus enhancing patient accessibility and treatment options. Furthermore, Ambulatory Surgical Centers are gaining traction due to the shifting preference towards outpatient surgeries, which offer faster recovery times and lower costs compared to traditional hospital admissions.

The combination of technological advancements and the increasing demand for urology services is leading to improved patient outcomes and efficiency within these settings. As urological diseases continue to rise in the US, the importance of these End Users in the healthcare landscape cannot be overstated, supporting overall growth in the US Urology Devices Market.

### **Urology Devices Market Gender Insights**

The US Urology Devices Market is intrinsically linked to gender, reflecting distinct medical needs and treatment approaches for both males and females. The market has shown substantial growth as advancements in technology and increasing awareness of urological health improve treatment options. Male-specific devices often focus on conditions such as benign prostatic hyperplasia and erectile dysfunction, representing a significant portion of procedures within the urology sector. Conversely, female urology devices address issues like urinary incontinence and pelvic floor disorders, which are gaining recognition due to growing advocacy and research emphasizing women's health.

The rising prevalence of these conditions, combined with an aging population, drives the demand within the market. Moreover, trends toward enhanced minimally invasive surgical techniques and more effective therapeutic devices further propel market growth. The US government has also acknowledged the importance of urological health by supporting Research and Development initiatives, which foster innovation within this gender-focused segment. Increasing investment in healthcare infrastructure and education around urological issues are pivotal in shaping the future landscape of the US Urology Devices Market, leading to improved outcomes for both men and women.

## **US Urology Devices Market Key Players and Competitive Insights**

The US Urology Devices Market is characterized by a complex competitive landscape, driven by advancements in technology, increased demand for minimally invasive procedures, and an aging population. Several key players dominate this market, competing on factors such as product innovation, quality, pricing, and customer service. The market is significantly influenced by the rising prevalence of urological conditions, leading to an increase in the utilization of urology devices. Companies are focusing on expanding their product portfolios and enhancing their market presence through strategic partnerships, mergers, and the adoption of cutting-edge technologies aimed at improving patient outcomes.

Additionally, regulatory changes and an emphasis on cost-effective solutions further shape the competitive dynamics within this sector.

Teleflex has established a significant footprint in the US Urology Devices Market through its innovative product offerings and a strong commitment to advancing healthcare solutions. The company's strengths lie in its comprehensive range of urology products, which includes catheters, drainage systems, and endoscopic devices that cater to various urological procedures. Teleflex's focus on research and development enables it to stay ahead of the competition by continually introducing new products that meet the evolving needs of healthcare providers and patients.

Moreover, the company's strong distribution network and strategic collaborations enhance its market reach, ensuring that its advanced urology solutions are widely available across the United States. This significant market presence, combined with a reputation for high-quality products, reinforces Teleflex's competitive advantage within the urology devices sector.

Acelity operates in the US Urology Devices Market with a focus on advanced wound care and related products that indirectly support urological health. The company is known for its innovative solutions such as negative pressure wound therapy that can aid in postoperative recovery for urological surgeries. Acelity's strengths lie in its robust research and development capabilities, allowing it to introduce cutting-edge technologies that enhance therapeutic outcomes. The company’s market presence has been bolstered through strategic mergers and acquisitions, which have expanded its product capabilities and distribution channels within the US.

Its commitment to quality and improvement in patient care positions Acelity favorably in the competitive landscape of the US Urology Devices Market. The combination of its extensive product range and a strong operational framework supports Acelity in maintaining a solid market presence while catering to the evolving needs of healthcare professionals in urology.

### **Key Companies in the US Urology Devices Market Include**

## **US Urology Devices Market Industry Developments**

Recent developments in the US Urology Devices Market indicate a growing trend in technological advancements and strategic mergers. Companies like Teleflex and Medtronic are focusing on innovative solutions to enhance patient outcomes and increase market penetration. There has been significant growth in the market valuation of key players, with Boston Scientific experiencing notable increases in share prices driven by their comprehensive product portfolio and successful launch of advanced urology products over the past two years. In March 2023, Stryker Corporation announced the acquisition of a urology device technology company aiming to expand its offerings in robotic-assisted surgery.

Additionally, advancements in minimally invasive techniques for urological procedures have surged, reflecting changing preferences among healthcare providers. The continuous rise in the aging population and increasing prevalence of urological conditions have further fueled demand for urology devices. Companies like Johnson and Johnson and Coloplast are investing heavily in Research and Development to stay competitive in this dynamic environment. This activity in the market signifies a robust and rapidly evolving landscape in the US Urology Devices Market.

## **US Urology Devices Market Segmentation Insights**

### **Urology Devices Market Device Type Outlook**

### **Urology Devices Market Application Outlook**

### **Urology Devices Market End User Outlook**

### **Urology Devices Market Gender Outlook**

## Market Drivers

### Growing Awareness and Education

美国[泌尿设备](https://www.marketresearchfuture.com/reports/urology-devices-market-1120)市场受益于对泌尿健康的日益关注和教育。旨在消除泌尿疾病污名化的活动使更多人寻求医疗建议和治疗。美国泌尿学会等组织提供资源和信息，使患者能够更好地理解自己的病情。这种提高的意识转化为对泌尿设备的更大需求，因为患者更有可能追求治疗选择。此外，针对医疗专业人员的教育倡议确保他们充分了解泌尿设备的最新进展，进一步推动市场增长，因为他们向患者推荐这些解决方案。

### Government Initiatives and Funding

美国泌尿设备市场受益于各种旨在改善医疗保健获取和质量的政府倡议。联邦项目，如国家卫生研究院对泌尿研究的资金，在推动新设备和治疗方式的发展中发挥着关键作用。此外，促进预防护理和早期诊断的政策有助于提高对泌尿设备的意识和利用。医疗保险和医疗补助服务中心还支持对创新泌尿治疗的报销，进一步激励医疗提供者采用先进技术。这种支持性的监管环境促进了泌尿设备市场的增长，鼓励投资和创新。

### Rising Prevalence of Urological Disorders

美国泌尿设备市场因泌尿疾病（如尿失禁、良性前列腺增生和肾结石）的流行率上升而经历增长。根据国家糖尿病和消化及肾脏疾病研究所的数据，数百万美国人受到这些疾病的影响，导致对有效治疗选择的需求加大。患者数量的激增需要开发和采用先进的泌尿设备，这对于诊断和管理至关重要。随着医疗提供者寻求改善患者结果，市场可能会扩大，推动创新解决方案以应对这些普遍的健康问题。

### Technological Innovations in Urology Devices

美国泌尿设备市场受到快速技术进步的显著影响。微创手术技术、机器人辅助手术和先进成像技术等创新正在改变泌尿护理的格局。例如，激光碎石设备的引入彻底改变了肾结石的治疗，为患者提供了更快的恢复时间和减少的并发症。此外，人工智能在诊断工具中的整合提高了识别泌尿疾病的准确性和效率。这些技术突破不仅改善了患者护理，还刺激了市场增长，因为医疗机构投资于最先进的泌尿设备以保持竞争力。

### Aging Population and Increased Healthcare Demand

美国泌尿设备市场受到老龄化人口的显著影响，老年人更容易受到泌尿疾病的影响。随着婴儿潮一代的持续老龄化，对泌尿设备的需求预计将急剧上升。根据美国人口普查局的数据，65岁及以上的人口预计到2060年将翻一番，导致前列腺癌和尿失禁等疾病的流行率增加。这一人口结构的变化需要开发和提供专门的泌尿设备，以满足老年人的独特需求。因此，制造商可能会专注于创造创新解决方案，以应对这一不断增长的人口所面临的挑战。

## Future Outlook

预计美国泌尿设备市场在2025至2035年间将以19.99%的年均增长率增长，受技术进步、泌尿疾病发病率上升和医疗支出增加的推动。

到2035年，泌尿设备市场预计将强劲增长，受创新和需求增加的推动。

## Segment Insights

### 按应用：泌尿外科（最大）与泌尿监测（增长最快）

美国泌尿设备市场在其各个应用细分领域中展现出良好的市场份额分布，其中泌尿外科占据最大份额。泌尿外科涵盖了一系列外科手术和工具，是泌尿护理的重要组成部分。其他细分领域包括泌尿诊断、泌尿治疗和泌尿监测，每个领域对整体格局的贡献都很大，但与外科相比规模较小。

泌尿外科（主导）与泌尿监测（新兴）

泌尿外科在美国泌尿设备市场中占据主导地位，特点是其广泛的外科仪器和设备，旨在有效进行泌尿干预。该细分领域受益于技术的持续进步，改善了手术结果和患者安全。相反，泌尿监测作为一个新兴细分领域正在获得关注。该领域专注于创新设备，帮助持续评估泌尿状况，受到对预防护理和[慢性病管理](https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981)日益重视的推动，使其成为一个关键的增长领域。

### 按设备类型：内窥镜设备（最大）与外科仪器（增长最快）

在美国泌尿设备市场中，内窥镜设备占据最大份额，反映了它们在各种泌尿手术中的广泛应用。紧随其后，外科仪器正在获得关注，受到外科干预和技术进步的推动。导管和支架也对市场有所贡献，尽管程度较小，而透析设备对慢性患者仍然至关重要，显著影响整体份额分布。

该细分领域的增长趋势主要受到技术进步和泌尿疾病发生率上升的影响。对微创手术的偏好推动了对内窥镜设备的需求，而外科仪器则经历了快速创新，导致其被指定为增长最快的细分领域。总体而言，患者安全和治疗效率推动了泌尿设备市场的这些动态。

内窥镜设备（主导）与导管（新兴）

内窥镜设备在美国泌尿设备市场中占据主导地位，因其在诊断和治疗程序中的多功能性和效率。它们促进了微创手术，缩短了患者的恢复时间。这种主导地位得益于持续的技术进步和对门诊手术的日益偏好。相反，导管虽然是新兴的，但在患者护理中发挥着关键作用，尤其是在需要长期管理的慢性病患者中。导管材料和设计的创新旨在提高舒适度和减少并发症，使其成为一个重要的增长领域。它们在家庭护理环境中的日益应用进一步表明了一个新兴趋势，迎合了患者和医疗提供者的偏好。

### 按最终用户：医院（最大）与泌尿诊所（增长最快）

在美国泌尿设备市场中，医院在最终用户细分领域中占据主导地位，因其先进的设施和更大的患者量，占据了相当大的份额。门诊手术中心也对市场做出了重要贡献，受益于对门诊护理和微创手术的日益偏好。泌尿诊所和研究机构虽然相对较小，但在专业护理和创新中发挥着关键作用，进一步丰富了该领域。

医院（主导）与泌尿诊所（新兴）

医院是美国泌尿设备市场的主导参与者，以其丰富的资源、熟练的人员和全面的泌尿服务而闻名。它们通常投资于最新技术，确保提供尖端治疗以应对复杂的泌尿问题。泌尿诊所作为该领域的重要实体，因对个性化护理和专业治疗的需求上升而获得关注。它们专注于特定的泌尿疾病，允许量身定制的方法，通常导致更快的恢复时间，使其成为寻求针对性解决方案的患者的首选。

## Competitive Benchmarking

泌尿设备市场的特点是动态的竞争格局，受到技术进步、泌尿疾病日益普遍和老龄化人口增长的推动。波士顿科学（美国）、美敦力（美国）和强生（美国）等主要参与者在战略上处于有利位置，以利用创新并扩大市场份额。波士顿科学（美国）专注于开发微创解决方案，而美敦力（美国）则强调数字健康整合和以患者为中心的技术。强生（美国）通过战略收购和合作伙伴关系增强其产品组合，共同塑造了一个优先考虑先进治疗选择和改善患者结果的竞争环境。
市场结构似乎适度分散，主要参与者采用各种商业策略来优化其运营。当地制造和增强供应链效率是这些公司常用的策略，使其能够迅速响应市场需求。这些主要参与者的集体影响力促进了一个竞争氛围，在这里，创新和运营卓越至关重要，推动了增长和市场份额。
2025年12月，波士顿科学（美国）宣布推出其最新的泌尿设备，该设备整合了人工智能技术以提高诊断准确性。这一战略举措不仅使公司处于技术创新的前沿，还满足了对泌尿治疗精确度日益增长的需求。人工智能的整合可能改善患者结果并简化临床工作流程，增强波士顿科学的竞争优势。
2025年11月，美敦力（美国）推出了一款专为泌尿患者设计的新远程医疗平台，使远程监测和咨询成为可能。这一举措反映了向数字健康解决方案的日益趋势，使美敦力能够增强患者参与度和可及性。通过投资远程医疗，美敦力可能会加强其市场地位，满足医疗服务提供者和患者不断变化的需求。
2025年10月，强生（美国）完成了对一家专注于创新导管技术的有前景的泌尿初创公司的收购。这一收购表明强生（美国）致力于扩大其产品供应并增强其技术能力。通过整合该初创公司的专业知识，公司可能加速其创新管道，更有效地响应市场需求。
截至2026年1月，泌尿设备市场的当前竞争趋势包括向数字化、可持续性和人工智能整合的明显转变。战略联盟越来越多地塑造市场格局，使公司能够集中资源和专业知识。展望未来，竞争差异化预计将演变，更加注重创新和技术，而非基于价格的竞争。优先考虑供应链可靠性和先进技术解决方案的公司可能会在这一快速变化的环境中蓬勃发展。

## Recent News & Developments

美国泌尿设备市场的最新发展表明，技术进步和战略合并的趋势日益增长。泰乐芬和美敦力等公司专注于创新解决方案，以提高患者结果并增加市场渗透。主要参与者的市场估值显著增长，波士顿科学的股价因其全面的产品组合和过去两年成功推出先进泌尿产品而显著上涨。2023年3月，史赛克公司宣布收购一家泌尿设备技术公司，旨在扩大其在机器人辅助手术中的产品供应。

此外，泌尿手术的微创技术的进步激增，反映了医疗服务提供者偏好的变化。老龄化人口的持续增加和泌尿疾病的发生率上升进一步推动了对泌尿设备的需求。强生和科乐派等公司在研发方面投入巨资，以在这一动态环境中保持竞争力。市场的这一活动标志着美国泌尿设备市场的强劲和快速发展的格局。

## Report Scope

| 2024年市场规模 | 113.7（亿美元） |
| --- | --- |
| 2025年市场规模 | 138.9（亿美元） |
| 2035年市场规模 | 843.9（亿美元） |
| 年复合增长率（CAGR） | 19.99%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | 波士顿科学（美国）、美敦力（美国）、强生（美国）、百特国际（美国）、科乐派（丹麦）、泰乐芬（美国）、库克医疗（美国）、史赛克（美国）、UroGen制药（美国） |
| 覆盖的细分市场 | 应用、设备类型、最终用户 |
| 主要市场机会 | 整合先进的微创技术，提高美国泌尿设备市场的患者结果。 |
| 主要市场动态 | 技术进步推动美国泌尿设备市场的创新，提高患者结果和运营效率。 |
| 覆盖的国家 | 美国 |

## Frequently Asked Questions

**Q: 美国泌尿设备市场目前的估值是多少？**
A: 美国泌尿设备市场在2024年的估值为113.7亿美元。

**Q: 到2035年，美国泌尿设备市场的预计市场估值是多少？**
A: 预计到2035年，市场将达到843.9亿美元。

**Q: 在2025年至2035年的预测期内，美国泌尿设备市场的预期年均增长率是多少？**
A: 在预测期内，市场的预期年均增长率为19.99%。

**Q: 哪些公司被认为是美国泌尿设备市场的关键参与者？**
A: 关键参与者包括波士顿科学公司、迈瑞医疗、强生公司、百特国际、科尔普拉斯、泰利弗克、库克医疗、史赛克和优罗基药业。

**Q: 美国泌尿设备市场的主要应用细分领域是什么？**
A: 主要应用细分领域包括泌尿外科、泌尿诊断、泌尿治疗和泌尿监测。

**Q: 2024年泌尿治疗细分领域的表现如何？**
A: 2024年，泌尿治疗细分领域的估值为45.4亿美元。

**Q: 美国泌尿设备市场内镜设备细分领域的估值是多少？**
A: 内镜设备细分领域在2024年的估值为22.7亿美元。

**Q: 2024年哪个最终用户细分领域的估值最高？**
A: 在2024年，医院细分领域的估值最高，达到35亿美元。

**Q: 到2035年，泌尿诊断的预计增长是多少？**
A: 泌尿诊断细分领域预计到2035年将增长到255.6亿美元。

**Q: 预计在美国泌尿设备市场中，哪种设备类型将看到显著增长？**
A: 外科仪器在2024年的估值为28.4亿美元，预计将看到显著增长。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-urology-devices-market-16386*